Can a simple questionnaire keep patients on track after cancer surgery?

NCT ID NCT06092281

First seen Aug 17, 2026 ยท Last updated Aug 17, 2026

Summary

This trial tests whether having patients complete a questionnaire about follow-up care, plus receiving feedback, can improve their adherence to scheduled endoscopic surveillance after endoscopic submucosal dissection (ESD) for early gastrointestinal growths. The study will enroll 500 adults who have had ESD and will compare those who receive the questionnaire and feedback with those who do not. The goal is to see if this educational approach increases the number of patients who attend their follow-up endoscopies on time, which could help catch any recurrence early.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Questionnaire and feedback on compliance-related education
What this could lead to
If effective, this simple, low-cost approach could help more patients attend crucial follow-up endoscopies, potentially reducing recurrence and improving outcomes after ESD.
What could go wrong
The trial is early and focuses on a behavioral intervention, so its impact may be limited or not generalizable. Compliance depends on many factors beyond education, and the study's success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENT COMPLIANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Xijing Hospital of Digestive Disease

    RECRUITING

    Xi'an, Shaanxi, 710032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.